These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8997547)

  • 1. A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia.
    Herrmann WM; Stephan K; Gaede K; Apeceche M
    Dement Geriatr Cogn Disord; 1997; 8(1):9-17. PubMed ID: 8997547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
    Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
    Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of organic brain syndrome with nicergoline given once a day].
    Ladurner G; Erhart P; Erhart C; Scheiber V
    Wien Klin Wochenschr; 1991; 103(1):8-14. PubMed ID: 2014712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study.
    Battaglia A; Bruni G; Ardia A; Sacchetti G
    J Am Geriatr Soc; 1989 Apr; 37(4):295-302. PubMed ID: 2646350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Nicergoline Treatment of Mild to Moderate Senile Dementia : Results of a Multicentre, Double-Blind, Placebo-Controlled Study.
    Nappi G; Bono G; Merlo P; Borromei A; Caltagirone C; Lomeo C; Martucci N; Fabbrini G; Annoni K; Battaglia A
    Clin Drug Investig; 1997 Jun; 13(6):308-16. PubMed ID: 27519492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].
    Saletu B; Hochmayer I; Grünberger J; Böhmer F; Paroubek J; Wicke L; Neuhold A
    Wien Med Wochenschr; 1987 Nov; 137(22):513-24. PubMed ID: 3324497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
    Kanowski S; Hoerr R
    Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Pentoxifylline Multi-Infarct Dementia Study.
    Eur Neurol; 1996; 36(5):315-21. PubMed ID: 8864715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia.
    Le Bars PL; Kieser M; Itil KZ
    Dement Geriatr Cogn Disord; 2000; 11(4):230-7. PubMed ID: 10867450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R
    Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.
    Pantoni L; Bianchi C; Beneke M; Inzitari D; Wallin A; Erkinjuntti T
    J Neurol Sci; 2000 Apr; 175(2):116-23. PubMed ID: 10831772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxiracetam in the treatment of primary degenerative and multi-infarct dementia: a double-blind, placebo-controlled study.
    Maina G; Fiori L; Torta R; Fagiani MB; Ravizza L; Bonavita E; Ghiazza B; Teruzzi F; Zagnoni PG; Ferrario E
    Neuropsychobiology; 1989; 21(3):141-5. PubMed ID: 2693996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
    Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM
    Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 24-month, double-blind, placebo-controlled multicentre pilot study of the efficacy and safety of nicergoline 60 mg per day in elderly hypertensive patients with leukoaraiosis.
    Bès A; Orgogozo JM; Poncet M; Rancurel G; Weber M; Bertholom N; Calvez R; Stehlé B
    Eur J Neurol; 1999 May; 6(3):313-22. PubMed ID: 10210912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relations between symptomatology and brain function in dementias: double-blind, placebo-controlled, clinical and EEG/ERP mapping studies with nicergoline.
    Saletu B; Anderer P; Semlitsch HV
    Dement Geriatr Cogn Disord; 1997; 8 Suppl 1():12-21. PubMed ID: 9205834
    [No Abstract]   [Full Text] [Related]  

  • 16. Moving from the question of efficacy to the question of therapeutic relevance: an exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam.
    Herrmann WM; Stephan K
    Int Psychogeriatr; 1992; 4(1):25-44. PubMed ID: 1391670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ergoloids and ischaemic strokes; efficacy and mechanism of action.
    Elwan O; Helmy AA; Tamawy ME; Naseer MA; Banhawy IE; Kader AA; Elwan F
    J Int Med Res; 1995; 23(3):154-66. PubMed ID: 7649339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superiority of antagonic-stress composition versus nicergoline in gerontopsychiatry.
    Schneider F; Popa R; Mihalas G; Stefanigă P; Mihalas IG; Măties R; Mateescu R
    Ann N Y Acad Sci; 1994 Jun; 717():332-42. PubMed ID: 8030850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial.
    Ditzler K
    Arzneimittelforschung; 1991 Aug; 41(8):773-80. PubMed ID: 1781796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.